We are thrilled to announce that YINGCHI TMS has received new FDA granted clearances for two major treatment indications: ✔ YINGCHI rTMS for Obsessive-Compulsive Disorder (OCD) – K243459 ✔ Intermittent Theta Burst Stimulation (iTBS) for Major Depressive Disorder – K243460 So far, YINGCHI TMS has been approved by FDA for rTMS treating OCD, rTMS treating MDD,... Read more
Date/Time:5 - 8 April, 2025 Location:Madrid, Spain YINGCHI Booth:Stand 12 Detail Information:https://epa-congress.org/ YINGCHI is pleased to announce our participation in the 33rd European Congress of Psychiatry (EPA 2025), taking place in Madrid, Spain, from April 5-8, 2025. As one of the most significant events in the field of psychiatry, EPA brings together leading experts, researchers, and industry... Read more
According to surveys, 7%-12% of pregnant women worldwide are affected by major depressive disorder (MDD). If depression during pregnancy is not treated, it can lead to numerous adverse consequences. Current primary treatment methods include psychotherapy, medication, and electroconvulsive therapy, but these come with side effects and risks. In recent years, transcranial magnetic stimulation (TMS), as... Read more
Date/Time:23–26 February, 2025 Location:Kobe Portopia Hotel / Kobe International Conference CentreKobe, Japan YINGCHI Booth: No. 38 Detail Information:https://www.elsevier.com/events/conferences/all/international-brain-stimulation-conference YINGCHI TMS is proud to announce its participation in the 6th International Brain Stimulation Conference, scheduled to take place from 23–26 February in Kobe. We will be showcasing our flagship products at Booth No. 38, highlighting the latest advancements in... Read more
In January 2025, Professor Duan Xujun's team from the University of Electronic Science and Technology published a groundbreaking study in the internationally renowned journal Biological Psychiatry, titled "Personalized theta-burst stimulation enhances social skills in young minimally verbal children with autism: a double-blind randomized controlled trial". The study utilized personalized brain imaging analysis technology and implemented... Read more
Intended Use: The Pulsed Magnetic Stimulation Device is intended for non-invasive stimulation of the human central and/or peripheral nervous system. Indications: Adjuvant therapy for Major Depressive Disorder (MDD), Neuropathic pain, Obsessive-compulsive disorder (OCD), Parkinson's disease, Motor disorder at the Post-acute stage of stroke. Warnings: All operators must consider the following clinical warnings before proceeding with patient... Read more
